In breast cancer, GLS and GLS2 are overexpressed at distinct levels depending on the histological subtype, and cells may display dependency on glutamine to survive [51], GLS2 being investigated as a protumorigenic gene [23]. The gene discussed is GLS; the disease is breast carcinoma.